FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074456441> ?p ?o ?g. }

• W2074456441 endingPage "200" @default.
• W2074456441 startingPage "194" @default.
• W2074456441 abstract "Objective To examine the efficacy of trospium chloride and tolterodine on the renal parenchymal inflammatory process and upper urinary dilation in rats with chronic partial upper urinary tract obstruction. Materials and Methods A total of 32 rats were divided into 4 groups: group 1, control; group 2, obstruction; group 3, obstruction plus tolterodine; and group 4, obstruction plus trospium chloride. In all groups, except for group 1, partial upper urinary tract obstruction was induced by embedding the upper quarter of the right ureter into the psoas muscle for 14 days. At the end of the experiment, the rats were killed. The catalase, malondialdehyde, and protein carbonyl levels were determined in renal tissue. Tubular dilation and parenchymal inflammation were evaluated using hematoxylin-eosin staining. Smooth muscle actin and cytoglobin were examined with immunohistochemical staining. Results The obstruction group demonstrated severe pelvic dilation and parenchymal inflammation and increased smooth muscle actin staining in the wall of upper urinary tract (P <.05). The treatment of the rats with tolterodine and trospium chloride markedly attenuated the inflammatory alterations and reduced tubular dilation. This treatment also reduced elevated oxidative stress product levels and restored the depleted renal antioxidant enzyme. Conclusion These findings imply that increased renal pelvic pressure can contribute to renal parenchymal injury in chronic pelvic upper urinary tract obstruction. Antimuscarinic medications such as tolterodine and trospium chloride exert renoprotective effects, probably by prevention of pelvic pressure increases. To examine the efficacy of trospium chloride and tolterodine on the renal parenchymal inflammatory process and upper urinary dilation in rats with chronic partial upper urinary tract obstruction. A total of 32 rats were divided into 4 groups: group 1, control; group 2, obstruction; group 3, obstruction plus tolterodine; and group 4, obstruction plus trospium chloride. In all groups, except for group 1, partial upper urinary tract obstruction was induced by embedding the upper quarter of the right ureter into the psoas muscle for 14 days. At the end of the experiment, the rats were killed. The catalase, malondialdehyde, and protein carbonyl levels were determined in renal tissue. Tubular dilation and parenchymal inflammation were evaluated using hematoxylin-eosin staining. Smooth muscle actin and cytoglobin were examined with immunohistochemical staining. The obstruction group demonstrated severe pelvic dilation and parenchymal inflammation and increased smooth muscle actin staining in the wall of upper urinary tract (P <.05). The treatment of the rats with tolterodine and trospium chloride markedly attenuated the inflammatory alterations and reduced tubular dilation. This treatment also reduced elevated oxidative stress product levels and restored the depleted renal antioxidant enzyme. These findings imply that increased renal pelvic pressure can contribute to renal parenchymal injury in chronic pelvic upper urinary tract obstruction. Antimuscarinic medications such as tolterodine and trospium chloride exert renoprotective effects, probably by prevention of pelvic pressure increases." @default.
• W2074456441 created "2016-06-24" @default.
• W2074456441 creator A5000624863 @default.
• W2074456441 creator A5025818084 @default.
• W2074456441 creator A5029217633 @default.
• W2074456441 creator A5041751806 @default.
• W2074456441 creator A5070633442 @default.
• W2074456441 date "2013-07-01" @default.
• W2074456441 modified "2023-10-01" @default.
• W2074456441 title "Effects of Tolterodine and Trospium Chloride on Renal Damage Induced by Partial Upper Urinary Tract Obstruction" @default.
• W2074456441 cites W129942261 @default.
• W2074456441 cites W1567614586 @default.
• W2074456441 cites W1576298134 @default.
• W2074456441 cites W1672203549 @default.
• W2074456441 cites W1775749144 @default.
• W2074456441 cites W1936558856 @default.
• W2074456441 cites W1984936527 @default.
• W2074456441 cites W1997088049 @default.
• W2074456441 cites W1999384039 @default.
• W2074456441 cites W2000917485 @default.
• W2074456441 cites W2005313412 @default.
• W2074456441 cites W2006542398 @default.
• W2074456441 cites W2015271862 @default.
• W2074456441 cites W2017892284 @default.
• W2074456441 cites W2026522667 @default.
• W2074456441 cites W2038362167 @default.
• W2074456441 cites W2045090220 @default.
• W2074456441 cites W2050067038 @default.
• W2074456441 cites W2053624919 @default.
• W2074456441 cites W2064683380 @default.
• W2074456441 cites W2071803835 @default.
• W2074456441 cites W2073059009 @default.
• W2074456441 cites W2081722675 @default.
• W2074456441 cites W2136481808 @default.
• W2074456441 cites W2149232097 @default.
• W2074456441 cites W2411195080 @default.
• W2074456441 cites W2414707118 @default.
• W2074456441 cites W90990995 @default.
• W2074456441 cites W969915667 @default.
• W2074456441 doi "https://doi.org/10.1016/j.urology.2013.01.030" @default.
• W2074456441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23453648" @default.
• W2074456441 hasPublicationYear "2013" @default.
• W2074456441 type Work @default.
• W2074456441 sameAs 2074456441 @default.
• W2074456441 citedByCount "1" @default.
• W2074456441 countsByYear W20744564412023 @default.
• W2074456441 crossrefType "journal-article" @default.
• W2074456441 hasAuthorship W2074456441A5000624863 @default.
• W2074456441 hasAuthorship W2074456441A5025818084 @default.
• W2074456441 hasAuthorship W2074456441A5029217633 @default.
• W2074456441 hasAuthorship W2074456441A5041751806 @default.
• W2074456441 hasAuthorship W2074456441A5070633442 @default.
• W2074456441 hasConcept C126322002 @default.
• W2074456441 hasConcept C126894567 @default.
• W2074456441 hasConcept C142724271 @default.
• W2074456441 hasConcept C204787440 @default.
• W2074456441 hasConcept C2778941218 @default.
• W2074456441 hasConcept C2781020410 @default.
• W2074456441 hasConcept C2993461684 @default.
• W2074456441 hasConcept C71924100 @default.
• W2074456441 hasConcept C77411442 @default.
• W2074456441 hasConceptScore W2074456441C126322002 @default.
• W2074456441 hasConceptScore W2074456441C126894567 @default.
• W2074456441 hasConceptScore W2074456441C142724271 @default.
• W2074456441 hasConceptScore W2074456441C204787440 @default.
• W2074456441 hasConceptScore W2074456441C2778941218 @default.
• W2074456441 hasConceptScore W2074456441C2781020410 @default.
• W2074456441 hasConceptScore W2074456441C2993461684 @default.
• W2074456441 hasConceptScore W2074456441C71924100 @default.
• W2074456441 hasConceptScore W2074456441C77411442 @default.
• W2074456441 hasIssue "1" @default.
• W2074456441 hasLocation W20744564411 @default.
• W2074456441 hasLocation W20744564412 @default.
• W2074456441 hasOpenAccess W2074456441 @default.
• W2074456441 hasPrimaryLocation W20744564411 @default.
• W2074456441 hasRelatedWork W1849600561 @default.
• W2074456441 hasRelatedWork W1991746308 @default.
• W2074456441 hasRelatedWork W2015291356 @default.
• W2074456441 hasRelatedWork W2016702375 @default.
• W2074456441 hasRelatedWork W2084567809 @default.
• W2074456441 hasRelatedWork W2317040632 @default.
• W2074456441 hasRelatedWork W2336206380 @default.
• W2074456441 hasRelatedWork W2405742691 @default.
• W2074456441 hasRelatedWork W2604444929 @default.
• W2074456441 hasRelatedWork W2768162379 @default.
• W2074456441 hasVolume "82" @default.
• W2074456441 isParatext "false" @default.
• W2074456441 isRetracted "false" @default.
• W2074456441 magId "2074456441" @default.
• W2074456441 workType "article" @default.